153 related articles for article (PubMed ID: 21923429)
1. Clinically significant drug interactions in younger and older human immunodeficiency virus-positive patients receiving antiretroviral therapy.
Yiu P; Nguyen NN; Holodniy M
Pharmacotherapy; 2011 May; 31(5):480-9. PubMed ID: 21923429
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy.
Miller CD; El-Kholi R; Faragon JJ; Lodise TP
Pharmacotherapy; 2007 Oct; 27(10):1379-86. PubMed ID: 17896893
[TBL] [Abstract][Full Text] [Related]
3. Differences in rates of diarrhea in patients with human immunodeficiency virus receiving lopinavir-ritonavir or nelfinavir.
Guest JL; Ruffin C; Tschampa JM; DeSilva KE; Rimland D
Pharmacotherapy; 2004 Jun; 24(6):727-35. PubMed ID: 15222662
[TBL] [Abstract][Full Text] [Related]
4. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V
Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential clinically significant drug interactions in HIV-infected patients: a comprehensive therapeutic approach.
Iniesta-Navalón C; Franco-Miguel JJ; Gascón-Cánovas JJ; Rentero-Redondo L
HIV Med; 2015 May; 16(5):273-9. PubMed ID: 25523089
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral medication errors among hospitalized patients with HIV infection.
Rastegar DA; Knight AM; Monolakis JS
Clin Infect Dis; 2006 Oct; 43(7):933-8. PubMed ID: 16941379
[TBL] [Abstract][Full Text] [Related]
7. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.
Patel N; Abdelsayed S; Veve M; Miller CD
Ann Pharmacother; 2011 Mar; 45(3):317-24. PubMed ID: 21386025
[TBL] [Abstract][Full Text] [Related]
8. The quality of pharmacotherapy in older veterans discharged from the emergency department or urgent care clinic.
Hastings SN; Sloane RJ; Goldberg KC; Oddone EZ; Schmader KE
J Am Geriatr Soc; 2007 Sep; 55(9):1339-48. PubMed ID: 17767675
[TBL] [Abstract][Full Text] [Related]
9. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients.
Tseng A; Szadkowski L; Walmsley S; Salit I; Raboud J
Ann Pharmacother; 2013 Nov; 47(11):1429-39. PubMed ID: 24285760
[TBL] [Abstract][Full Text] [Related]
10. Clinically significant drug interactions between antiretroviral and co-prescribed drugs in HIV infected patients: retrospective cohort study.
Al Sayed HAH; Sharif-Askari NS; Rahimi MR
Med Pharm Rep; 2022 Jul; 95(3):260-266. PubMed ID: 36060510
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
[TBL] [Abstract][Full Text] [Related]
12. Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings?
Rowe KA; Makhubele B; Hargreaves JR; Porter JD; Hausler HP; Pronyk PM
Int J Tuberc Lung Dis; 2005 Mar; 9(3):263-9. PubMed ID: 15786888
[TBL] [Abstract][Full Text] [Related]
13. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Horberg MA; Hurley LB; Klein DB; Follansbee SE; Quesenberry C; Flamm JA; Green GM; Luu T
Arch Surg; 2006 Dec; 141(12):1238-45. PubMed ID: 17178967
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study.
Reynolds NR; Testa MA; Marc LG; Chesney MA; Neidig JL; Smith SR; Vella S; Robbins GK;
AIDS Behav; 2004 Jun; 8(2):141-50. PubMed ID: 15187476
[TBL] [Abstract][Full Text] [Related]
15. Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans.
Kraemer KL; McGinnis KA; Skanderson M; Cook R; Gordon A; Conigliaro J; Shen Y; Fiellin DA; Justice AC
Med Care; 2006 Aug; 44(8 Suppl 2):S44-51. PubMed ID: 16849968
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients.
Orlando G; Meraviglia P; Cordier L; Meroni L; Landonio S; Giorgi R; Fasolo M; Faggion I; Riva A; Zambelli A; Beretta R; Gubertini G; Dedivitiis G; Jacchetti G; Cargnel A
HIV Med; 2006 Nov; 7(8):549-57. PubMed ID: 17105515
[TBL] [Abstract][Full Text] [Related]
17. Older age and the response to and tolerability of antiretroviral therapy.
Silverberg MJ; Leyden W; Horberg MA; DeLorenze GN; Klein D; Quesenberry CP
Arch Intern Med; 2007 Apr; 167(7):684-91. PubMed ID: 17420427
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antiretroviral-related errors and interventions by the clinical pharmacist in hospitalized HIV-infected patients.
Carcelero E; Tuset M; Martin M; De Lazzari E; Codina C; Miró J; Gatell J
HIV Med; 2011 Sep; 12(8):494-9. PubMed ID: 21395966
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients.
Jongwutiwes U; Sungkanuparph S; Kiertiburanakul S
Jpn J Infect Dis; 2008 Mar; 61(2):111-5. PubMed ID: 18362398
[TBL] [Abstract][Full Text] [Related]
20. An assessment of adverse effects of antiretroviral therapy on the development of HIV positive children by observation of dental mineralization chronology.
Trigueiro M; Tedeschi-Oliveira SV; Melani RF; Ortega KL
J Oral Pathol Med; 2010 Jan; 39(1):35-40. PubMed ID: 20359308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
